Project Number 1U01AG066722-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator WATTERSON, DANIEL MARTIN Principal Investigator First Name DANIEL MARTIN Principal Investigator Last Name WATTERSON Awardee Organization NORTHWESTERN UNIVERSITY AT CHICAGO Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,475,773 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN
